Logo image of PD

PAGERDUTY INC (PD) Stock Fundamental Analysis

NYSE:PD - New York Stock Exchange, Inc. - US69553P1003 - Common Stock - Currency: USD

15.31  +0.25 (+1.66%)

After market: 15.31 0 (0%)

Fundamental Rating

3

Overall PD gets a fundamental rating of 3 out of 10. We evaluated PD against 283 industry peers in the Software industry. PD has a bad profitability rating. Also its financial health evaluation is rather negative. PD is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PD had positive earnings in the past year.
In the past year PD had a positive cash flow from operations.
PD had negative earnings in each of the past 5 years.
Of the past 5 years PD 4 years had a positive operating cash flow.
PD Yearly Net Income VS EBIT VS OCF VS FCFPD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

PD has a Return On Assets (-5.87%) which is comparable to the rest of the industry.
PD has a worse Return On Equity (-41.95%) than 65.37% of its industry peers.
Industry RankSector Rank
ROA -5.87%
ROE -41.95%
ROIC N/A
ROA(3y)-10.14%
ROA(5y)-10.48%
ROE(3y)-47.62%
ROE(5y)-40.38%
ROIC(3y)N/A
ROIC(5y)N/A
PD Yearly ROA, ROE, ROICPD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100

1.3 Margins

With an excellent Gross Margin value of 82.96%, PD belongs to the best of the industry, outperforming 90.81% of the companies in the same industry.
In the last couple of years the Gross Margin of PD has remained more or less at the same level.
PD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-0.54%
PD Yearly Profit, Operating, Gross MarginsPD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

3

2. Health

2.1 Basic Checks

PD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PD has been reduced compared to 1 year ago.
PD has more shares outstanding than it did 5 years ago.
PD has a worse debt/assets ratio than last year.
PD Yearly Shares OutstandingPD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
PD Yearly Total Debt VS Total AssetsPD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that PD is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PD (0.87) is worse than 62.19% of its industry peers.
The Debt to FCF ratio of PD is 4.16, which is a neutral value as it means it would take PD, 4.16 years of fcf income to pay off all of its debts.
PD has a better Debt to FCF ratio (4.16) than 60.42% of its industry peers.
PD has a Debt/Equity ratio of 3.03. This is a high value indicating a heavy dependency on external financing.
PD has a Debt to Equity ratio of 3.03. This is amonst the worse of the industry: PD underperforms 80.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF 4.16
Altman-Z 0.87
ROIC/WACCN/A
WACC9.62%
PD Yearly LT Debt VS Equity VS FCFPD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

PD has a Current Ratio of 1.93. This is a normal value and indicates that PD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.93, PD is in line with its industry, outperforming 58.66% of the companies in the same industry.
PD has a Quick Ratio of 1.93. This is a normal value and indicates that PD is financially healthy and should not expect problems in meeting its short term obligations.
PD has a Quick ratio of 1.93. This is comparable to the rest of the industry: PD outperforms 59.01% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
PD Yearly Current Assets VS Current LiabilitesPD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

5

3. Growth

3.1 Past

PD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.97%, which is quite good.
The Revenue has grown by 8.56% in the past year. This is quite good.
Measured over the past years, PD shows a very strong growth in Revenue. The Revenue has been growing by 22.95% on average per year.
EPS 1Y (TTM)8.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.41%
Revenue 1Y (TTM)8.56%
Revenue growth 3Y18.44%
Revenue growth 5Y22.95%
Sales Q2Q%9.3%

3.2 Future

PD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.38% yearly.
PD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.91% yearly.
EPS Next Y13.16%
EPS Next 2Y14.8%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue Next Year8.12%
Revenue Next 2Y8.63%
Revenue Next 3Y7.91%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PD Yearly Revenue VS EstimatesPD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
PD Yearly EPS VS EstimatesPD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.01, PD is valued on the expensive side.
81.27% of the companies in the same industry are more expensive than PD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PD to the average of the S&P500 Index (23.99), we can say PD is valued slightly cheaper.
A Price/Forward Earnings ratio of 15.92 indicates a correct valuation of PD.
Based on the Price/Forward Earnings ratio, PD is valued cheaper than 84.10% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PD to the average of the S&P500 Index (20.35), we can say PD is valued slightly cheaper.
Industry RankSector Rank
PE 18.01
Fwd PE 15.92
PD Price Earnings VS Forward Price EarningsPD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

PD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PD is cheaper than 92.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.86
EV/EBITDA N/A
PD Per share dataPD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PD's earnings are expected to grow with 14.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.37
PEG (5Y)N/A
EPS Next 2Y14.8%
EPS Next 3Y14.38%

0

5. Dividend

5.1 Amount

PD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PAGERDUTY INC

NYSE:PD (5/7/2025, 8:27:02 PM)

After market: 15.31 0 (0%)

15.31

+0.25 (+1.66%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-13 2025-03-13/amc
Earnings (Next)05-29 2025-05-29/amc
Inst Owners92.42%
Inst Owner Change-1.06%
Ins Owners6.54%
Ins Owner Change7%
Market Cap1.39B
Analysts73.33
Price Target20.68 (35.08%)
Short Float %11.28%
Short Ratio7.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.15%
Min EPS beat(2)32.22%
Max EPS beat(2)46.08%
EPS beat(4)4
Avg EPS beat(4)32.75%
Min EPS beat(4)21.72%
Max EPS beat(4)46.08%
EPS beat(8)8
Avg EPS beat(8)49.23%
EPS beat(12)12
Avg EPS beat(12)78.04%
EPS beat(16)16
Avg EPS beat(16)64.18%
Revenue beat(2)0
Avg Revenue beat(2)-1.22%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)-0.89%
Revenue beat(4)0
Avg Revenue beat(4)-2.24%
Min Revenue beat(4)-3.36%
Max Revenue beat(4)-0.89%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.47%
Revenue beat(16)3
Avg Revenue beat(16)-1.15%
PT rev (1m)-2.19%
PT rev (3m)-8.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6%
EPS NY rev (1m)0%
EPS NY rev (3m)4.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.56%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-1.69%
Valuation
Industry RankSector Rank
PE 18.01
Fwd PE 15.92
P/S 2.98
P/FCF 12.86
P/OCF 11.83
P/B 10.74
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.85
EY5.55%
EPS(NY)0.96
Fwd EY6.28%
FCF(TTM)1.19
FCFY7.77%
OCF(TTM)1.29
OCFY8.45%
SpS5.13
BVpS1.43
TBVpS-0.31
PEG (NY)1.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.87%
ROE -41.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.96%
FCFM 23.19%
ROA(3y)-10.14%
ROA(5y)-10.48%
ROE(3y)-47.62%
ROE(5y)-40.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-0.54%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 3.03
Debt/FCF 4.16
Debt/EBITDA N/A
Cap/Depr 46%
Cap/Sales 2.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 0.87
F-Score7
WACC9.62%
ROIC/WACCN/A
Cap/Depr(3y)47.55%
Cap/Depr(5y)63.23%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.41%
EPS Next Y13.16%
EPS Next 2Y14.8%
EPS Next 3Y14.38%
EPS Next 5YN/A
Revenue 1Y (TTM)8.56%
Revenue growth 3Y18.44%
Revenue growth 5Y22.95%
Sales Q2Q%9.3%
Revenue Next Year8.12%
Revenue Next 2Y8.63%
Revenue Next 3Y7.91%
Revenue Next 5YN/A
EBIT growth 1Y32.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.04%
EBIT Next 3Y25.93%
EBIT Next 5YN/A
FCF growth 1Y68.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y63.8%
OCF growth 3YN/A
OCF growth 5YN/A